4D Molecular Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
4D Molecular Therapeutics is a mid-sized biotechnology company based in Emeryville, California, focused on developing durable, disease-targeted genetic medicines. Its lead program, 4D-150, aims to function as a backbone therapy for blinding retinal vascular diseases by delivering anti-VEGF treatments over multi-year periods through a single intravitreal injection, reducing the treatment burden associated with frequent bolus injections. The primary indication for 4D-150 is wet age-related macular degeneration, with diabetic macular edema as a secondary target. Its second program, 4D-710, is designed to deliver and express the CFTR transgene in the lungs after aerosol administration, addressing cystic fibrosis. Operating within the biotechnology research sector, the company pursues collaborations to extend its reach into new disease areas. A concrete development is a strategic partnership with Otsuka Pharmaceutical to develop and commercialize 4D-150 for retinal vascular diseases in Japan, China, Australia, and other Asia-Pacific markets.
1-888-653-2347 
support@leadiq.com 
